Finance Director · Pharmaceuticals
Finance for Pharma Finance Directors
Running finance in a pharmaceutical company means dealing with R&D cycles that stretch over a decade, patent cliffs that can wipe out revenue overnight, and pricing negotiations with national health systems that follow their own logic. Here you'll find lessons built around those realities: how the industry actually makes money, who the players are, from originators to generics to payers, and what the regulation means for your numbers.
Alongside the sector content, you get the full finance curriculum, interactive tools to test your understanding, and an action playbook you can apply directly to your reporting, forecasting, and board conversations. A sector-specific assessment shows you exactly where you stand and what to work on next, so you spend your time on what actually moves you forward.
27 lessons · ~5 h · resumes where you left off
Your program
A focused program built on your vertical's content: the sector first, then your discipline applied to it.
The generalist Finance track
The full craft of the discipline, beyond your sector.
More resources
Interactive tools
Frequently asked questions
Who is "Finance for Pharma Finance Directors" for?
It's built for finance directors, controllers and CFOs working in pharmaceutical companies, plus anyone moving into the sector from another industry. The content assumes you already read a P&L and a cash flow statement, and focuses on what changes when your business runs on decade-long R&D cycles and negotiated prices.
What's the difference between this and a general finance curriculum?
You get both. The full finance curriculum is included, and on top of it sit lessons on pharma economics: how the industry makes money, the roles of originators, generics manufacturers and payers, and how regulation lands in your numbers. The general material gives you the mechanics, the sector material tells you which mechanics matter in pharma.
Where should I start if I've just moved into pharma from another industry?
Start with the sector assessment. It shows where your knowledge of pharma economics stands against the rest of the finance material, so you skip what you already know and go straight to patent cliffs, payer negotiations and R&D capitalisation. Then work through the sector lessons before returning to the general curriculum.
Do I need an account, and is there anything to pay?
Reading is free and open, with no payment involved. An account only serves to save your progress and your assessment results so you can pick up where you left off.
Does this lead to a diploma or a recognised certification?
No. There's no diploma, no state-recognised certification and no affiliation with a school or university. What you take away is working knowledge of pharma finance and a playbook you can apply to your reporting and board conversations.
What exactly is in the action playbook?
It's the practical layer of the pharma finance content: what to change in your reporting, your forecasting and the way you present numbers to a board when revenue depends on patent expiry dates and price negotiations with national health systems. It's meant to be used on your own files, not read once and filed away.